Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesPreferred Shares IssuedShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Carlsmed (CARL) Depreciation and Depletion (2024 - 2026)

Carlsmed posted quarterly Depreciation and Depletion of $100000.0 for Q1 2026, little changed year-on-year from $100000.0 in Q1 2025, and little changed on a QoQ basis from $100000.0 in Q4 2025.

Carlsmed (CARL) has 3 years of Depreciation and Depletion data on file, last reported at $100000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Depreciation and Depletion changed 0.0% year-over-year to $100000.0; the trailing twelve-month figure through Mar 2026 stood at $400000.0 (up 33.33% YoY), and the FY2025 full-year result was $300000.0, up 200.0% from the prior year.
  • Depreciation and Depletion for Q1 2026 stood at $100000.0, roughly flat from $100000.0 in the prior quarter.
  • Across five years, Depreciation and Depletion topped out at $100000.0 in Q2 2024 and bottomed at $100000.0 in Q2 2024.
  • The 3-year median for Depreciation and Depletion is $100000.0 (2024), against an average of $100000.0.
  • Peak annual rise in Depreciation and Depletion reached 0.0% in 2025, while the deepest fall reached 0.0% in 2025.
  • A 3-year view of Depreciation and Depletion shows it stood at $100000.0 in 2024, then changed by 0.0% to $100000.0 in 2025, then changed by 0.0% to $100000.0 in 2026.
  • The last three Depreciation and Depletion figures came in at $100000.0 (Q1 2026), $100000.0 (Q4 2025), and $100000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation and Depletion (Qtr)
1 Veeva Systems 30.85 Bn 24.28 Bn 622.47 Mn -
2 BrightSpring Health Services 12.29 Bn 11.41 Bn 482.22 Mn -
3 Healthequity 7.80 Bn 7.48 Bn 256.31 Mn 500,000.00
4 Hinge Health 4.82 Bn 4.51 Bn 154.23 Mn 300,000.00
5 Doximity 4.21 Bn 3.46 Bn 125.97 Mn 2.10 Mn
6 Waystar Holding 4.18 Bn 4.03 Bn 268.04 Mn 7.00 Mn
7 10x Genomics 3.78 Bn 3.24 Bn 106.18 Mn -
8 Privia Health 2.65 Bn 2.28 Bn 595.71 Mn 146,000.00
9 Omnicell 1.95 Bn 1.78 Bn 140.36 Mn 9.20 Mn
10 Carlsmed 298.68 Mn 201.48 Mn 12.43 Mn 100,000.00

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 100,000.00
Mar 31, 2026 100,000.00
Dec 31, 2025 100,000.00
Dec 31, 2025 100,000.00
Sep 30, 2025 100,000.00
Sep 30, 2025 100,000.00
Jun 30, 2025 100,000.00
Jun 30, 2025 100,000.00
Mar 31, 2025 100,000.00
Mar 31, 2025 100,000.00
Sep 30, 2024 100,000.00
Sep 30, 2024 100,000.00
Jun 30, 2024 100,000.00
Jun 30, 2024 100,000.00